香叶醇的研究进展-孙立宏

kyotorphinanaloguestothebrain.JMedChem[J].1998,41(20):3773-3781.[9]　OhtsukiS.Newaspectsoftheblood-brainbarriertrans-porters;itsphysiologicalrolesinthecentralnervoussys-tem[J].BiolPharmBull,2004,27(10):1489-1496.[10]　BoadoRJ,ZhangY,WangY,etal.Engineeringandexpressionofachimerictransferrinreceptormono-clonalantibodyforblood-brainbarrierdeliveryinthemouse[J].BiotechnolBioeng,2009,102(4):1251-1258.[11]　GranholmAC,AlbeckD,ckmanC,etal.Anon-inva-sivesystemfordeliveringneuralgrowthfactorsacrosstheblood-brainbarrier:areview[J].RevNeurosci,1998,9(1):31-55.[12]　WangJY,XuYR,HuangK,etal.Proliposometar-getingtorabbitbraintissue[J].JPharmPharmacol.1995,47(12A):1053-1054.[13]　SiegalT,HorowitzA,GabizonA.Doxorubicinencap-sulatedinstericallystabilizedliposomesforthetreat-mentofabraintumormodel:biodistributionandther-apeuticefficacy[J].JNeurosurg.1995,83(6):1029-1037.[14]　ShiG,GuoW,StephensonSM,etal.Efficientintra-cellulardrugandgenedeliveryusingfolatereceptor-targetedpH-sensitiveliposomescomposedofcationic/anioniclipidcombinations[J].JControlRelease,2002,80(1-3):309-319.[15]　HuwylerJ,WuD,PardridgeWM.Braindrugdeliveryofsmallmoleculesusingimmunoliposomes[J].ProcNatlAcadSciUSA,1996,93(24):1416-1419.[16]　KreuterJ.Influenceofthesurfacepropertiesonnano-particle-mediatedtransportofdrugstothebrain[J].JNanosciNanotechnol,2004,4(5):484-488.[17]　ChenY,SiddalingappaB,ChanPH,BensonHA.De-velopmentofachitosan-basednanoparticleformulationfordeliveryofahydrophilichexapeptide,dalargin[J].Biopolymers,2008,90(5):663-670.[18]　ShamenkovDA,PetrovVE,AlyautdinRN.Effectsofapolipoproteinsondalargintransportacrosstheblood-brainbarrier[J].BullExpBiolMed,2006,142(6):703-706.[19]　LoboC,LopesG,SilvaO,etal.Paclitaxelalbumin-boundparticles(abraxane)incombinationwithbevaci-zumabwithorwithoutgemcitabine:earlyexperienceattheUniversityofMiami/BramanFamilyBreastCancerInstitute[J].BiomedPharmacother,2007,61(9):531-533.[20]　CloughesyTF,BlackKL.Pharmacologicalblood-brainbarriermodificationforselectivedrugdelivery[J].JNeurooncol,1995,26(2):125-132.[21]　DahlinM,BjörkE.Nasalabsorptionof(S)-UH-301anditstransportintothecerebrospinalfluidofrats[J].IntJPharm,2000,195(1-2):197-205.(:2009-03-24)孙立宏1,孙立明2(1.,301500;2.,300193):　天然物质环保、低毒的优势明显,笔者对天然成分香叶醇的研究现状做一综述介绍。　从香叶醇的提取分离、定性定量、合成、应用着眼。　希望为香叶醇进一步开发利用奠定研究基础。:香叶醇;应用;提取分离;定性定量;合成:R284　　　:A　　　:1004-2407(2009)05-0428-03　　(-3,7--2,6--1-),“”,,0.883～0.886,nD201.4766,230℃,、。、、、、250,、、。、、。1　,,。,。:,5.4℃,1.33kPa,2.3℃。[1]CaCl2,,40g100g(52%),,500mL,3%,7h,CaCl2,90%。,2℃,,。[2],,600～700Pa,4.8～4.9kPa,150℃～152℃,6h,20/1,10/1,5/1,90%,95%。2　,β-。[3],β-。,,、,。。,250%～60%。[4]、、、、,170～175℃10h。、,。70.8%。。,,。[5],,。,。428　200910　24　53　,GC-MS、。IHNMRIR[6,7]。[6]GC-MS,,38,33,,β-、、、。[7]GC-MS,65,、、30,87.02%,,67.66%。4　4.1　以香叶醇为原料合成其它物质4.1.1　　,[8](2E)-3,7--2,6-,90%。(2E,6E)-3,7--8--2,6--1-(Q10)。[9],、-、、、,49.7%。[10]CH2Cl2-H2O-NaCl,,,,[2,3]-σ,Q10(2E,6E)-8--2,6--2,6--1-,7IHNMRIR,。(2E,6E)3,7,112,6,101E,Q。(E,E)-8-,[11]。,、、、5(E,E)-8-,35%。4.1.2　　N--2--N′-(3,7---2,6-)--1,2-(SQ109)Sequella。[12];2-、N1--2---1,2-,SQ109。(6,10,14,18--5,9,13,17--2-)。[13],,、36,36,8、3。4.2　药理作用4.2.1　　Yu[14],3--3-A。,,,。。Carnesecchi[15]70%,S,DNA,;50%。,40%,。StephanieCarnesecchi[16]DNA5-。(150mmol)5-。,5-(20mg/kg)(150mg/kg)53%;26%,5-[17]、、S180,HL-60。Burke[18]。4.2.2　　。[19]:,,,。,。,(0.1～0.3g·L-1),(mg·L-1)0.300.270.180.11。4.2.3　　[20]58。,pH4.5,、、。VanninaLorenzi[21],,。;(),。,,、。4.2.4　　[22]24、、,1000μg·cm-1,。Kyung-AhSeoa[23]CYP2B6。Ki6.810.3mol·L-1,CYP2B6Ki(1.8mol·L-1)。2,CYP2B6。(),CYP2B6。5　,。,,、。429　200910　24　5:[1]　,,,.[J].,1993,(3):1-3.[2]　,,,.[J].,2003,20(6):430-434.[3]　,,.[J].,1989,9(4):13-19.[4]　,,,.、[J].,2005,39(2):28-30.[5]　.[J].,1997,1(14):25-26.[6]　,,,.[J].,2000,35(7):462.[7]　,.[J].,2002,25(10):719-720.[8]　,,,.(2E)-3,7--2,6-[J].,1994,25(3):131-132.[9]　,,,.(2E,6E)-3,7--8--2,6--1-[J].,2007,24(6):339-342.[10]　,.Q(10)(2E,6E)-8--2,6--2,6--1-[J].,2007,5(2):241-243.[11]　,,,.(E,E)-8-[J].(),1997,36(6):120-122.[12]　,,.N--2--N′-(3,7---2,6-)--1,2-[J].,2007,17(5):279-298.[13]　.[J].,2005,27(11):641-643.[14]　YuSG,HildebrandtLA,ElsonCE.Geraniol,aninhibitorofmevalonatebiosynthesis,suppressesthegrowthofhepa-tomasandmelanomastransplantedtoratsandmice[J].JNutr,1995,125(11):2763-2767.[15]　CarnesecchiS,SchneiderY,CeralineJ,etal.Gerani-ol,acomponentofplantessentialoils,inhibitsgrowthandpolyaminebiosynthesisinhumancoloncancercells[J].JPharmacolExpTher,2001,298(1):197-200.[16]　StephanieCarnesecchi,RuiBras-Goncalves,AmyaouchBra-daia,etal.Geraniol,acomponentofplantessentialoils,modulatesDNAsynthesisandpotentiates5-flu-orouracilefficacyonhumancolontumorxenografts[J].CancerLetters,2004,215:53-59.[17]　.[J].,1989,24(5):366.[18]　BurkeYD,StarkMJ,RoachSL,etal.Inhibitionofpan-creaticcancergrowthbythedietaryisoprenoidsfarnesolandgeraniol[J].Lipids,1997,32(2):151-156.[19]　,,,.[J].,1980,2(1):27-30.[20]　,,,.[J].,2002,15(1):32-36.[21]　VanninaLorenzi,AlainMuselli,AntoineFrancoisBernar-dini,etal.GeraniolRestoresAntibioticActivitiesagainstultidrug-ResistantIsolatesfromGram-NegativeSpecies[J].AntimicrobAgentsChemother,2009,53(5):2209-2211.[22]　,,.[J].,2